Amelioration of ischemia‐reperfusion–induced muscle injury by the recombinant human MG53 protein

Abstract

Our data suggest that rhMG53 may be a potential therapy for protection against muscle trauma. A mouse model appears to be a better choice than a rat model for evaluating potential treatments for protecting skeletal muscle.